Study Objectives: Non-apnea sleep disorder (NASD) increases the risk of hypertension, type 2 diabetes mellitus, chronic kidney disease, cardiovascular disease, and stroke. However, the risk and the time interval of NASD to female infertility has not been thoroughly understood. Our study aimed to determine whether NASD increases the subsequent risk of female infertility. Methods: This study utilized outpatient and inpatient data from the Longitudinal Health Insurance Database between 2000 and 2010 in Taiwan. We enrolled 50,154 females aged 20 to 45 years old and diagnosed with NASD as outpatients ≥2 times or hospitalized, 16,718 of them who matched our criteria were assigned to the study group. For each NASD patient, two comparison patients were frequency matched by age (each 5-year span), index date, and comorbidities as the control cohort with a total of 33,436 patients. We conducted Cox proportional hazard regression analysis to estimate the effects of NASD on female infertility. Results: The NASD cohort had an adjusted hazard ratio (HR) of subsequent female infertility of 3.718-fold higher than that of the cohort without sleep disorders. In the stratified age group, NASD had the highest impact on 26-30 years old, with an adjusted HR of 5.146 followed by 31-35 years old (adjusted HR = 3.356). The Kaplan-Meier analysis also showed that in the sixth year of follow-up, the incidence of female infertility was higher in the NASD cohort than in the general population cohort till the end of the follow-up. Conclusions: Our study demonstrates that NASD patients are at a higher risk of developing female infertility.
INTRODUCTION
Sleep disorders (SDs) are a group of diseases characterized by having disturbances in the amount, quality or timing of sleep, or in behaviors of physiological conditions associated with sleep. 1 In Taiwan, the prevalence of SD in the general population is 4.2%, 2 and approximately 20% of women aged 25-44 years old have experienced SD. 3 According to the International Classification of Sleep Disorders (ICSD-3) (American Academy of Sleep Medicine [AASM], 2014), SD is divided into seven categories: insomnia, sleep-related breathing disorders, central disorders of hypersomnolence, circadian rhythm sleep disorders, parasomnias, sleep-related movement disorders, and other sleep disorders. 1 Female infertility and low birth rate are significant public health issues with a profound psychosocial and economic influence. The prevalence of infertility has increased since 1990, and approximately 48.5 million couples worldwide suffered from infertility in 2010. 4 Female infertility is defined as the inability of a woman within childbearing age to become pregnant despite having frequent and unprotected intercourse for at least one year. 5 It can be mainly caused by endometriosis, polycystic ovaries and other ovulatory disorders, tubal blockage and other tubal abnormalities, pelvic adhesion, hyperprolactinemia, and congenital or acquired uterine abnormalities. 6 Non-apnea sleep disorder (NASD) refers to SDs other than sleep apnea. NASD has recently been associated with increasing risks of other comorbidities, including hypertension, type 2 diabetes mellitus (DM), chronic kidney disease (CKD), cardiovascular disease, and stroke. [7] [8] [9] [10] Observatory studies have pointed the association between shift work and menstrual irregularities, reproductive dysfunction, adverse pregnancy outcome, and infertility. [11] [12] [13] The mechanism for infertility secondary to sleep disorders maybe the activation of the hypothalamic-pituitaryadrenal (HPA) axis.
14 Moreover, recent study has pointed out that NASD is associated with subsequent erectile dysfunction. 15 In the modern society, more and more people suffered from NASD. Based on the previous studies, we have hypothesized that NASD maybe related to subsequent female infertility. Therefore, we conducted a longitudinal nationwide population-based cohort study using the Taiwan National Health Insurance Research Database (NHIRD) to investigate whether NASD increases the subsequent risk of female infertility.
METHODS

Data Sources
Our data were accessed from the Taiwan National Health Insurance Research Database (NHIRD). Taiwan has initiated the National Health Insurance (NHI) program in 1995.
It covers approximately 99% of the 23.74 million residents in Taiwan, and 97% of clinics are enrolled in the NHI system. 16 The NHIRD includes many registration records of the general public in Taiwan, such as outpatient, inpatient, and emergency data. Diagnoses in the NHIRD were coded by physicians according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). The accuracy and high validity of diagnoses in the NHIRD have been demonstrated in previous articles. 17, 18 Therefore, the NHIRD offers representative data for medical and health-related research fields. To protect the privacy of all people registered in the program, the NHIRD encrypts and converts the identification numbers of all NHIRD records. Our study protocol was approved by the Institutional Review Board of Tri-Service General Hospital (TSGHIRB No.2-105-05-082).
Study Participants
This study enrolled 986,713 outpatients and inpatients from the Longitudinal Health Insurance Database (LHID) between 2000 and 2010 in Taiwan. Females aged 20-45 years old who were diagnosed with NASD as outpatients ≥2 times, or were hospitalized with NASD were included, for a total of 80,140 individuals. The date of newly diagnosed NASD was used as the index date. NASD included sleep disturbances, unspecified (ICD-9-CM code: 780.50); other insomnia (ICD-9-CM code: 780.52); other hypersomnia (ICD-9-CM code: 780.54); disruptions of the 24-hour sleep-wake cycle (ICD-9-CM code: 780.55); dysfunctions associated with sleep stages or arousal from sleep (ICD-9-CM code: 780.56); unspecified sleep-related movement disorder (ICD-9-CM code 780.58); other sleep disturbances (ICD-9-CM code: 780.59); and specific disorders of sleep of non-organic origin (ICD-9-CM code: 307.4). We excluded patients with sleep apnea (ICD-9-CM codes: 780.51, 780.53, and 780.57), NASD before 2000, infertility before tracking, and male-related infertility (ICD-9-CM code: 606); patients who received radiation therapy (ICD-9-CM V58.0), chemotherapy (ICD-9-CM V58.1), or genital organ-related surgery (ICD-9-CM OP codes: 65-71); and patients with infertility-causing factors, such as ovarian dysfunction (ICD-9-CM code: 256; polycystic ovaries = ICD-9-CM 256.4), endometriosis (ICD-9-CM code: 617), and uterine leiomyoma (ICD-9-CM code: 218) (Figure 1 ). Participants who matched our criteria were assigned to the study cohort. For each NASD patient, two comparisons were frequency matched by age (each 5-year span), index date, and comorbidities as the control cohort. Common comorbidities such as hypertension (ICD-9-CM code: 401-405), type 2 DM (ICD-9-CM code: 250), hyperlipidaemia (ICD-9-CM code: 272), chronic obstructive pulmonary disease (COPD; ICD-9-CM codes: 490-496), CKD (ICD-9-CM code: 585), ischaemic heart disease (IHD; ICD-9-CM code: 410-414), heart failure (HF; ICD-9-CM code: 428), stroke (ICD-9-CM code: 430-438), cancer (ICD-9-CM codes: 140-238), anxiety (ICD-9-CM code: 300.00), and depression (ICD-9-CM code: 296.2-296.3, 300.4) were listed to compare the baseline characteristics between two groups. Moreover, in this study, we included common factors of female infertility, such as obesity (ICD-9-CM code: 278), hyperoestrogenism (ICD-9-CM code: 256.0), polycystic ovaries (PCOS; ICD-9-CM code: 256.4), irregular menstrual cycle (ICD-9-CM code: 626.4), endometriosis (ICD-9-CM code: 617), uterine leiomyoma (ICD-9-CM code: 218), Cushing's syndrome (ICD-9-CM code: 255.0), thyrotoxicosis with or without goiter (ICD-9-CM code: 242), and acquired hypothyroidism (ICD-9-CM code: 244), to evaluate the confounding effects of NASD. Both the study group and control group were followed till the end of December 31, 2010.
Statistical Analysis
The demographic features and common comorbidities between the NASD patients and the comparison cohort were compared using the chi-squared test. The mean ages of both cohorts were measured using Student's t test. The incidence rate (per 10 5 person-years) of infertility was calculated according to sex, age, and comorbidities for each cohort. Age, sex, and concomitant comorbidities were included in the multivariable model for adjustment. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using multivariable Cox proportional hazard models. We evaluated the cumulative incidence of NASD to female infertility using the Kaplan-Meier analysis and log-rank test. All analyses were conducted using SPSS 22.0 software, with a two-tailed test p < .05 for statistical significance.
RESULTS
The study included 16,718 female patients with newly diagnosed NASD and 33,436 female patients in the control cohort during the period between 2000 and 2010 ( Table 1 ). The mean follow-up time was 5.02 ± 5.25 years in the NASD cohort and 5.10 ± 5.46 years in the control cohort (Supplementary Table S1 ). By the end of follow-up, 29 participants in the NASD cohort had developed infertility with 34 participants in the control cohort ( Figure 1 and Table 2 ). The average ages were 42.46 ± 7.06 and 43.22 ± 7.51 years for the study and the comparison cohort, respectively (p = .001; Table 2 ). In the age-stratified NASD group, patients aged 36-40 years had the highest percentage of infertility (28.05%) followed by patients of ≥41 years (27.03%); patients aged 20-25 years had the lowest percentage (8.18%) (p < .001; Table 2 ). The baseline demographic characteristics and common comorbidities of the female patients are shown in Table 1 , and the follow-up results are shown in Table 2 .
During the follow-up period, the NASD cohort had a higher incidence of female infertility and a greater prevalence of concomitant comorbidities (except CKD, HF, cancer, polycystic ovaries, and Cushing's syndrome; Table 2 ). The mean duration of female infertility was 3.27 ± 2.37 years in the NASD population. The Kaplan-Meier analysis indicated that in the sixth year, the incidence of infertility was higher in the NASD cohort than in the general population cohort (p = .025), a finding that persisted until the end of the follow-up (log-rank; p = .001; Figure 2 ; Supplementary Table S2) .
NASD patients had a higher risk of female infertility compared with the control cohort (crude HR = 2.710 [95% CI, 1.640-4.478]; p < .001). After adjusting for age and other concomitant comorbidities, the HR of infertility for patients with NASD increased to 3.718 (95% CI = 2.156-6.412; p < .001; Table 3 ). Age is an important factor for female infertility in NASD patients. In Table 3 , the adjusted risk of female infertility in the 20-to 25-year age group was 13.8 times (95% CI = 4.264-44.659; p < .001) than the age group of ≥41 years. The age group was then stratified into patients with or without NASD to study the effect of age group to each cohort. Moreover, general population in the NHIRD without NASD (the unmatched group) was included as the baseline characteristic of each age group to female infertility (Supplementary Table S3 ). In patients with NASD, the risk of being infertile was 15.349 times (95% CI = 2.493-94.486; p < .001) greater in the 20-to 25-year age group than in the ≥41-year age group. In contrast, in the general population group, the adjusted HR of infertility in the 20-to 25-year age group was 0.675 (95% CI= 0.451-0.893; p < .001; Supplementary Table S3) compared with the ≥41-year age group. Of the concomitant comorbidities, PCOS was the dominant factor for infertility, with an adjusted HR of 90.361 (95% CI=34.833-234.407; p < .001), followed by endometriosis (adjusted HR = 11.877 [95% CI, 6.169-22.869]; p < .001).
Common comorbidities and the age group were stratified by using the Cox regression model and studied the impact of NASD on the study group and the control group (Table 4 ). The incidence rates of female infertility in the NASD and non-NASD group were 86.17 and 34.32 per 10 5 person-years, respectively (Table 4 ). In the stratified age group, NASD had the highest impact on patients aged 26-30 years, with an adjusted HR of 5.146 (95% CI=1.340-19.756; p < .001), followed by those aged 31-35 years (adjusted HR = 3.356 [95% CI, 1.282-8.784]; p = .015) ( Table 4) . NASD is a dominating factor among concomitant comorbidities. However, confounding interactions existed between NASD and several factors, including polycystic ovaries, endometriosis, and uterine leiomyoma. These interactions increased the risk of infertility, making patients with NASD were more likely to become infertile. Table 5 shows the risks of different types of NASDs to female infertility. Compared with the non-NASD cohort, patients with insomnia associated with 4.354 times risk of developing infertility (95% CI = 2.425-7.818; p < .001). . NASD = non-apnea sleep disorder; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; IHD = ischemic heart disease; HF = heart failure. CKD is a condition characterized by a gradual loss of kidney function over time. IHD refers to insufficient blood supply to the coronary arteries. HF refers to a condition when the heart is unable to pump effectively to maintain blood flow to meet the body's needs. . NASD = non-apnea sleep disorder; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; IHD = ischemic heart disease; HF = heart failure. CKD is a condition characterized by a gradual loss of kidney function over time. IHD refers to insufficient blood supply to the coronary arteries. HF refers to a condition when the heart is unable to pump effectively to maintain blood flow to meet the body's needs.
DISCUSSION
Our study demonstrates that NASD patients had a 3.718-fold risk of female infertility compared with the control cohort during an 11-year follow-up. The infertility rate among women between 15 and 45 years old in Taiwan is 10.01%, whereas the infertility rate increases to 24.57% among women aged 35 to 45 years (Supplementary Table S4) , which is consistent with the international infertility rate. 4 However, the infertility rate in the current study (0.13%) is lower than the others. This is because we have excluded patients with sleep apnea, NASD before 2000, infertility before tracking, and male-related infertility (ICD-9-CM code: 606); patients who received radiation therapy (ICD-9-CM V58.0), chemotherapy, etc.
In general population, women aged 20 to 25 years were less likely to become infertile than those in the ≥41-year-old group (adjusted HR = 0.675). However, in patients with NASD, the younger age group patients were more likely to become infertile. The NASD patients in the 20-to 25-year-old group had an adjusted risk 15.349 times greater than the ≥41-year age group. This may be due to the higher level of stress among the younger age group. We evaluated the level of stress by using anxiety Figure 2 -The Kaplan-Meier analysis for cumulative incidence of female infertility in female aged 20-45 years old stratified by non-apnea sleep disorders with log-rank test. Table S5 ).
The menstrual cycle involves the hypothalamus, pituitary, ovary, and endometrium. The hypothalamus releases the pulsatile gonadotropin-releasing hormone (GnRH), stimulating the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In the ovarian follicle, LH stimulates theca cells to produce androstenedione, whereas FSH stimulates the production of aromatase (Cyp19) catalyzing the conversion of androstenedione to oestradiol. The oestradiol causes positive feedback in the hypothalamus, increasing the secretion of GnRH and causing an LH surge. The LH surge then initiates the process of ovulation. 19 Kloss et al. 14 have hypothesized three potential mechanisms for infertility secondary to sleep disorders: First, NASDs activate the HPA axis which may interfere with reproduction. Second, the alteration of sleep duration or sleep continuity can activate HPA or independently alter reproductive hormones. Third, the circadian dysrhythmia may affect fertility and the related hormones. The activated HPA then affects sex hormones, such as LH, FSH, and progesterone, causing changes in menstruation, normal follicle development, and infertility. [20] [21] [22] [23] Moreover, HPA activation increases melatonin levels, which is associated with GnRH suppression and irregular ovulation. 22, 24 Melatonin is a significant circadian hormone. However, the exact role of melatonin in female infertility is not thoroughly understood. Cagnacci and colleagues have shown that melatonin enhances LH and FSH, possibly through GnRH during the follicular phase. 25 Reiter et al. demonstrated that melatonin can facilitate oocyte quality, ovulation, luteal function, and the development of embryo. 26, 27 Recent studies have noted that circadian dysrhythmia arising from shift work can lead to increased infertility, menstrual dysregulation, and miscarriage. [28] [29] [30] Davis and colleagues observed that among night shift workers, the melatonin level was lowered, but LH and FSH were increased. 31 Shreeve et al. also demonstrated that women with PCOS had increased levels of melatonin and oxidative stress compared with women who did not have PCOS. They hypothesized that this unique association may be the pathophysiology of PCOS, but this has not yet been confirmed. 32 Chronic insomnia is a disorder of hyperarousal caused by the interaction of both the physical and mental factors. 33 Vgontzas and colleagues demonstrated that patients with chronic insomnia have increased level of stress hormone compared with good sleepers. 34 The researchers found that individuals with chronic insomnia had increased levels of ACTH and cortisol compared with the control group when analyses were controlled for BMI. Since stress is related to female infertility, 35 patients with chronic insomnia had increased level of stress hormones, which may develop further into infertility. In this study, we found that among the different types of NASD, insomnia carried a 4.354-times risk of developing female infertility. Moreover, the mean duration to female infertility was 3.27 ± 2.37 years in the NASD population. The Kaplan-Meier analysis also indicated that in the sixth year, the incidence of infertility was higher in the NASD cohort than the general population cohort, and this difference persisted till the end of follow-up.
NASD has been associated with increased risks of concomitant comorbidities, such as hypertension, type 2 DM, HR= hazard ratio; CI = confidence interval; Adjusted HR = Adjusted variables listed in the table; NASD = non-apnea sleep disorder; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; IHD = ischemic heart disease; HF = heart failure. CKD is a condition characterized by a gradual loss of kidney function over time. IHD refers to insufficient blood supply to the coronary arteries. HF refers to a condition when the heart is unable to pump effectively to maintain blood flow to meet the body's needs. Table 3 ; CI = confidence interval. NASD = non-apnea sleep disorder; DM = diabetes mellitus; COPD = chronic obstructive pulmonary disease; CKD = chronic kidney disease; IHD = ischemic heart disease; HF = heart failure. CKD is a condition characterized by a gradual loss of kidney function over time. IHD refers to insufficient blood supply to the coronary arteries. HF refers to a condition when the heart is unable to pump effectively to maintain blood flow to meet the body's needs. CKD, cardiovascular disease, and stroke, 2,7-10 and our study had similar results. Although the exact mechanism underlying NASD and concomitant comorbidities is still unclear, studies have noted that objective short sleep duration and insomnia were associated with incident hypertension and atherosclerosis. 36, 37 In this study, we further evaluated the risks of female infertility associated with each comorbidity and studied the impact of NASD on female infertility in association with these comorbidities (Tables 3 and 4) . We found that concomitant comorbidities, including hypertension, type 2 DM, CKD, and obesity, had no impact on female infertility. It may be due to the small prevalence of these concomitant diseases in our cohort of relatively young female patients (Table 4) . PCOS (adjusted HR = 90.361) and endometriosis (adjusted HR = 11.877) were the only two factors related to female infertility in the Cox regression analysis. The result is similar to the findings of Leproult et al., showing that circadian misalignment or dysrhythmia is associated with increased insulin resistance and inflammation, 14, 38 which led to the development of PCOS and endometriosis. 39, 40 Moreover, we discovered that in NASD patients, the risks of female infertility increased in the presence of PCOS (adjusted HR = 7.791), endometriosis (adjusted HR = 4.932), and uterine leiomyoma (adjusted HR = 16.927) (Table 4) .
However, this study has limitations. First, we could not obtain detailed patient information regarding factors such as smoking habits, alcohol consumption, physical activity, socioeconomic status, and family history from the NHIRD. Second, infertility due to psychological reasons cannot be observed from the NHIRD. Third, we could not trace the data of patients who used assisted reproductive technologies. Finally, our study lacked data on objective sleep measurements and other psychological conditions and on the history of medication. Despite these limitations, the strength of this study is that it reports longitudinal results on the association between NASDs and the risk of subsequent female infertility events in a nationwide population-based cohort.
In conclusion, we have found a strong association between NASD and its subsequent risk to female infertility. In this modern society in which an increasing number of people are susceptible to NASD, we think our study can be a wake-up call for clinical practitioners as well as the general public. PYs = person-years; Adjusted HR = Adjusted Hazard ratio: Adjusted for the variables listed in Table 3 ; CI = confidence interval.
